Nigam K

Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

6 papers

ArticlePsychedelics

Psychological Adverse Effects of Psychedelic Use.

King F, Zambrano J, Mauney E +6

Europe PMC2026
ArticlePsilocybin

Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.

Beaussant Y, Sager Z, Brennan C +14

Europe PMC2026
ArticlePsilocybin

Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.

Beaussant Y, Tarbi E, Nigam K +9

Europe PMC2025
ArticleKetamine

Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review.

Shen MR, Campbell DE, Kopczynski A +4

Europe PMC2025
ArticlePsilocybin

Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.

Schipper S, Nigam K, Schmid Y +5

Europe PMC2024
ArticlePsychedelics

Psychedelic/entactogen‐assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care

Schipper S, Nigam K, Piechotta V +4

Europe PMC2022